When patients are treated with the anti-androgen flutamide, the suppressive effects of progesterone on LH release are partially restored (Eagleson et al., 2000), suggesting that hyperandrogenism plays a role in this impaired negative feedback. The gene discussed is PLOD1; the disease is hyperandrogenism.